Stay updated on Durvalumab with Chemoradiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab with Chemoradiation in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab with Chemoradiation in Lung Cancer Clinical Trial page
- Check7 days agoChange DetectedVersion 38 was added to the study record history on 2025-10-27. The page also shows the 'Study Status' navigation item, highlighting a new or updated section for viewing status.SummaryDifference0.4%

- Check14 days agoNo Change Detected
- Check35 days agoChange DetectedAdded a government operations notice and a version upgrade to v3.2.0; removed the v3.1.0 tag.SummaryDifference10%

- Check43 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content.SummaryDifference0.2%

- Check57 days agoChange DetectedUpdate to Revision: v3.0.2 and removal of the Back to Top element. Overall, a minor release with no substantive changes to core content.SummaryDifference0.6%

- Check64 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.6%

- Check71 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while some location-related terms have been removed.SummaryDifference42%

Stay in the know with updates to Durvalumab with Chemoradiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab with Chemoradiation in Lung Cancer Clinical Trial page.